肺功能测试:从COVID-19感染中恢复过来的患者的呼吸系统健康评估的主要依据
Sanjay Nehe1, Avinash Taksande1, Ranjit Ambad2
1Department of Physiology Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, DMIHER, Maharashtra, India.
Journal of pharmacy & bioallied sciences
|February 10, 2025
概括
肺功能测试揭示了COVID-19幸存者在病后三个月内持续存在的呼吸问题. 早期和定期的肺功能评估对于有效的管理和恢复至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 呼吸系统医学 呼吸系统医学
背景情况:
- 数以百万计的人受到COVID-19的影响,但肺功能数据在恢复后是有限的.
- 之前对COVID-19幸存者的呼吸功能研究的样本大小小小.
- 这项研究调查了COVID-19康复患者的较大队列中的肺功能.
研究的目的:
- 为了确定患者从急性COVID-19疾病中康复后的肺功能状态.
- 评估COVID-19感染对呼吸系统的长期影响.
- 为改善患者管理策略提供数据.
主要方法:
- 招募了250名从急性疾病中康复的COVID-19患者的队列.
- 对参与者进行了肺功能测试 (PFT).
- 测量的关键PFT指数包括第一秒强制呼吸量 (FEV1),强制生命能力 (FVC) 和FEV1/FVC比率.
主要成果:
- 在COVID-19复苏后的三个月内,咳和喘息等呼吸系统症状在患者中持续存在.
- 康复的COVID-19患者报告了心理问题,包括孤独,恐惧,焦虑和抑郁.
- 所有测量的呼吸系统参数即使在经过三个月的急性COVID-19疾病康复后仍然受到影响.
结论:
- 在出院前推对COVID-19幸存者进行肺功能评估和定期随访.
- 呼吸练习和普拉那亚玛可以提高恢复结果.
- 肺功能测试对于监测患者在COVID-19后恢复至关重要.
相关概念视频
Pulmonary Function Tests
290
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
290
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Pneumonia III: Complications and Assessment
146
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
146
COPD: Management Using Bronchodilators and Corticosteroids
174
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
174


